Introduction: Glaucoma is associated with diabetes. Metformin is one of the first therapeutic options for diabetes and may act to overcome the incidence or severity of glaucoma.
INTRODUCTION:
Glaucoma is considered as an importantreason that is characterized by being irreversible cause for blindnessworldwide [1] [2] .There are several types of glaucoma, but the most prevalent type is called primary open angle glaucoma (POAG) 3 . The occurrence of glaucoma has been associated with several risk factors including older age, family history, myopia, and ocular hypertension [4] [5] [6] . Diabetes mellitus (DM) is considered as real health problem with increasing prevalence globally because of changed trends in lifestyles and increased age of population. Furthermore, several complications are associated with DM such as severe acute and chronic complications 2, 5. DM is widely prevalent and its prevalence increased from 2.8% in 2000 to 4.4% in 2030 among all age groups at global level 7 .
The relationship between DM and glaucoma was investigated through several studies; some studies reported significant relationship [8] [9] . Other studies did not report a significant relationship between DM and glaucoma [10] [11] . The relationship between the treatment of metformin and glaucoma was investigated.
Lin et al 12 conducted a study in which 150 016 patients with diabetes mellitus were included. A total of 5893 (3.9%) developed glaucoma. They also found that patients who were prescribed the highest level of metformin(>1110 g in 2 years) to have one quarter reduction rate in developing OAG. They also found that the use of 1 gram of metformin was able to decrease the risk of developing OAG by 0.16%.
STUDY OBJECTIVES:
to study the prevalence of glaucoma in Jordanian diabetic patients and to investigate the association of glaucoma and metformin treatment in diabetic Jordanian patients.
METHODS AND SUBJECTS:
Study design: a retrospective study was conducted to collect data from files of diabetic patients who attended internal medicine clinics at Royal Medical City.
Files were eligible if the status of glaucoma is available and if the treatment with metformin is indicated. The data included demographic variables including age and gender; and medical conditions such as diabetes, glaucoma, and metformin treatment. Data will be entered into excel sheet and will be further analyzed using SPSS version 20. Data wer presented as frequencies, percentages, means and standard deviation. The relationship between variables was investigated using Chi-Square, and One way Anova. Significance was considered at alpha < 0.05.
RESULTS:
As indicated in table 1, the mean age of participants was 56.95+ 11.98 years; 53.2% of participants were males; the majority of participants were prescribed for metformin therapy; the mean metformin dose was 1069.52+ 954.86 mg; and the prevalence of glaucoma was 50%. 
DISCUSSION:
We conducted this study to achieve two objectives,the prevalence of glaucoma in Jordanian diabetic patients and to investigate the association of glaucoma and metformin treatment in diabetic Jordanian patients. The prevalence of glaucoma among diabetic patients was 50%. The study of Lin et al 12 showed that the prevalence of glaucoma was about 4%, but they included larger sample size in their study as compared with our study. Actually, they determined the prevalence of glaucoma in general population. In their study, Fredrick et al 13 reported that the prevalence of retinopathy was about 30% among diabetic patients.
The present study did not show a significant association between glaucoma and study variables including age, gender, metformin use and dose. In literature, studies gave various outcomes regarding the relationship between glaucoma and diabetes. Some studies have confirmed a significant relationship between diabetes and glaucoma which implies metformin use and dose [8] [9] . On the other hand, other studies did not confirm such a relationship [10] [11] . In their study, Lin et al 12 confirmed a significant relationship between metformin dose and glaucoma prevalence.
CONCLUSION:
The present study showed that the glaucoma is not associated significantly with study variables included in the study.
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